Eyeing up the global aesthetics market
Here are some lessons we learned during a recent interview with CFO Alan Ol...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Written By
Patrick Brennan
7 March 2017
Here are some lessons we learned during a recent interview with CFO Alan Ol...
Read MoreWith a strong focus on the collaboration needed to solve problems common to...
Read MoreUsing the pioneering Kymouse human antibody expression platform, Kymab are ...
Read MoreIn March of this year, an article published in Science made waves throughou...
Read MoreEquity crowdfunding is particulary suited to life sciences
Read MoreWhat is equity crowdfunding? To any average member of Joe public, the word ...
Read MoreHaving recently listed on the London Stock Exchange, CEO Doug Doerfler tell...
Read MoreChristian Girard, expert in orphan drugs, competitive intelligence, in/out ...
Read MoreBiotech and Money had the opportunity to speak with Alastair Smith, the CEO...
Read MoreBiotech companies have fared well recently in the IPO market in both the US...
Read MoreIan has over 25 years of international experience in management and transac...
Read MoreComprising a team with expertise in both development and commercialisation,...
Read MoreThe LSX Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
© 2018 All Rights Reserved By LSX Ltd
Add Your Response